DOSSIER · 13F-HR · Q4 2025

Data Collective IV GP, LLC

$59M in tracked AUM across 3 positions as of Q4 2025.

DC
CIK 0001664974 · last filed Dec 31, 2025
Total AUM
$59M
as of Q4 2025
Holdings
3
positions
Whale Score
61
61
tracked
Activity
no data
changes this Q
AI Analysis · Q4 2025

Portfolio Overview

Data Collective IV GP, LLC presents a highly concentrated, high-conviction investment portfolio characterized by significant volatility and active management. As of the reporting period ending September 30, 2025, the firm’s total assets under management (AUM) stood at approximately $67.98 million, representing a sharp decline of 47.7% from the previous quarter's $129.91 million. This dramatic reduction in portfolio value is attributable to a combination of active asset li...

The portfolio exhibits extreme concentration, holding only four securities. This lack of diversification suggests an investment philosophy focused on high-alpha opportunities rather than risk mitigation through broad indexing. The top two positions—Evolv Technologies and Recursion Pharmaceuticals—account for approximately 98.2% of the total portfolio value, indicating that the firm's performance is inextricably linked to the fortunes of these two specific companies.

Key Holdings

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
EVLV
Evolv Technologies Holdings, Inc.
$33M4.6M56.2%
02
RXRX
Recursion Pharmaceuticals, Inc.
$24M5.9M41.5%
03
BRD1EUR
Mind Medicine (MindMed) Inc.
$1M100K2.3%

Filing history

2025Q4Dec 31
$59M 13.9%
3 positionsView →
2025Q3Sep 30
$68M 47.7%
4 positionsView →
2025Q2Jun 30
$130M 108.7%
5 positionsLocked
2025Q1Mar 31
$62M 72.5%
4 positionsLocked
2024Q4Dec 31
$226M 38.4%
6 positionsLocked
2024Q3Sep 30
$163M 14.6%
6 positionsLocked
2024Q2Jun 30
$143M 23.7%
6 positionsLocked
2024Q1Mar 31
$115M 4.6%
5 positionsLocked
2023Q4Dec 31
$121M 14.4%
5 positionsLocked
2023Q3Sep 30
$106M 21.8%
5 positionsLocked
2023Q2Jun 30
$135M 43.9%
6 positionsLocked
2023Q1Mar 31
$94M 1.4%
6 positionsLocked
Showing 12 of 17